21 CFR Part 806 · Medical Devices; Reports of Corrections and Removals

21 CFR 806.20

Records of corrections and removals not required to be reported

21 CFR 806.20 is the regulation titled “Records of corrections and removals not required to be reported” in 21 CFR Part 806, Medical Devices; Reports of Corrections and Removals. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
0 against 0 on the same dates in 2025
Most often cited with
21 CFR 820.100, in 1 letter
Closed out
0% of these letters have a published close-out
See the letter citing 21 CFR 806.20 →

Letters citing it, by year issued

It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 02023
  4. 12024
  5. 02025
  6. 02026

What FDA writes when it cites it

The finding headings that cite 21 CFR 806.20 most often, as written in the letters.

  • 1 letterFailure to keep a record of a correction or removal that contains information including a justification for not reporting the correction or removal action to FDA which shall contain conclusions and any follow-ups, and…

The regulation

Read the text of 21 CFR 806.20 (eCFR, as of Sep 1, 2026)

(a) Each device manufacturer or importer who initiates a correction or removal of a device that is not required to be reported to FDA under § 806.10 shall keep a record of such correction or removal.

(b) Records of corrections and removals not required to be reported to FDA under § 806.10 shall contain the following information:

(1) The brand name, common or usual name, classification, name and product code if known, and the intended use of the device.

(2) The unique device identifier (UDI) of the device, or the device identifier, universal product code (UPC), model, catalog, or code number of the device and the manufacturing lot or serial number of the device or other identification number.

(3) A description of the event(s) giving rise to the information reported and the corrective or removal action that has been, and is expected to be taken.

(4) Justification for not reporting the correction or removal action to FDA, which shall contain conclusions and any followups, and be reviewed and evaluated by a designated person.

(5) A copy of all communications regarding the correction or removal.

(c) The manufacturer or importer shall retain records required under this section for a period of 2 years beyond the expected life of the device, even if the manufacturer or importer has ceased to manufacture or import the device. Records required to be maintained under paragraph (b) of this section must be transferred to the new manufacturer or importer of the device and maintained for the required period of time.

[62 FR 27191, May 19, 1997, as amended at 63 FR 42233, Aug. 7, 1998; 78 FR 58821, Sept. 24, 2013]

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 806.20.

Latest letters citing it

The letter citing 21 CFR 806.20 that FDA posted most recently.

See the letter citing 21 CFR 806.20 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.